仁度生物(688193.SH)上半年净利润203.8万元，同比下降52.94%

Group 1 - The core viewpoint of the article highlights that RenDu Bio (688193.SH) reported a decline in both revenue and net profit for the first half of 2025 [1] Group 2 - The company achieved an operating revenue of 81.24 million yuan, representing a year-on-year decrease of 6.27% [1] - The net profit attributable to shareholders was 2.038 million yuan, reflecting a year-on-year decline of 52.94% [1] - The basic earnings per share stood at 0.06 yuan [1]